Toxicity Profiles In Vivo in Mice and Antitumour Activity in Tumour-Bearing Mice of Di- and Triorganotin Compounds

por Gielen, M., Willem, R., Dalil, H., de Vos, D., Kuiper, C. M., Peters, G. J.
Publicado 1998

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.

por Feller, N., Kuiper, C. M., Lankelma, J., Ruhdal, J. K., Scheper, R. J., Pinedo, H. M., Broxterman, H. J.
Publicado 1995

Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

por Versantvoort, C. H., Schuurhuis, G. J., Pinedo, H. M., Eekman, C. A., Kuiper, C. M., Lankelma, J., Broxterman, H. J.
Publicado 1993

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

por Moorsel, C J A van, Pinedo, H M, Veerman, G, Bergman, A M, Kuiper, C M, Vermorken, J B, van der Vijgh, W J F, Peters, G J
Publicado 1999

Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.

por Boven, E., Pinedo, H. M., van Hattum, A. H., Scheffer, P. G., Peters, W. H., Erkelens, C. A., Schlüper, H. M., Kuiper, C. M., van Ark-Otte, J., Giaccone, G.
Publicado 1998

Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.

por Schuurhuis, G. J., Broxterman, H. J., de Lange, J. H., Pinedo, H. M., van Heijningen, T. H., Kuiper, C. M., Scheffer, G. L., Scheper, R. J., van Kalken, C. K., Baak, J. P.
Publicado 1991